查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1641769

全球快速生育和妊娠檢測套組市場（按產品、測試類型和最終用戶分類）- 機會分析和產業預測，2024 年至 2033 年

Fertility and Pregnancy Rapid Test Kits Market By Product , By Test Type By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 240 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計快速不孕症和妊娠檢測套組市場規模將在 2023 年達到 15 億美元，到 2033 年將達到 31 億美元，2024 年至 2033 年的複合年成長率為 7.4%。

生育與妊娠快速檢測試劑盒市場-IMG1

快速不孕症和懷孕檢測套組是市售的診斷工具，旨在快速檢測尿液或唾液中的激素，以指示女性的不孕狀況或懷孕情況。這些測試為個人提供了一種方便且私密的方式來監測他們的生殖健康，而無需醫療保健專業人員的干涉。妊娠檢測套組可檢測人類絨毛膜促性腺激素分泌（一種在懷孕期間產生的激素）的存在，而不孕症檢測套組可檢測黃體激素和雌激素，這對排卵很重要。

全球快速不孕不育和妊娠檢測套組市場預計將出現強勁成長，原因包括人們對生殖健康的認知不斷提高以及在家檢測的便利性，尤其是那些希望懷孕的人。 。此外，由於生活型態因素和延遲生育導致的不孕不育率急劇上升，希望懷孕的夫妻對不孕症檢測套組的需求也隨之增加。根據世界衛生組織 (WHO) 今天發布的 2023 年調查，大約 17.5% 的成年人口患有不孕症。 2024 年不孕症統計數據顯示，全球整體有 4,850 萬對夫婦患有不孕症。這凸顯了對不孕症檢測套組的迫切需求，以幫助個人監測他們的生育週期並做出明智的決定。此外，快速不孕症和妊娠檢測套組相對便宜，對於希望監測生育能力而不需要頻繁就醫的個人來說，這是一種經濟實惠的選擇，從而顯著推動了市場成長。此外，這些套件在實體店和線上市場均廣泛銷售，消費者可以輕鬆獲得，進一步促進了市場的成長。早期檢測妊娠，特別是對於月經不規則的女性和想要快速確認妊娠的女性來說，進一步增加了對妊娠檢測套組的需求。儘管取得了進步，但一些檢測套組仍然會出現假陽性和假陰性結果，這對市場成長造成了重大阻礙。此外，其他生殖健康技術的興起，如數位排卵追蹤器和提供更詳細見解的行動應用程式，可能會減少對傳統檢測套組的需求，從而抑制市場成長。相反，更高的準確度、方便用戶使用的設計和更快的結果等檢測套組技術的創新正在擴大這些產品的吸引力和可靠性，預計這將在預測期內推動全球市場的擴張。此外，隨著意外懷孕負擔的增加和墮胎率的驚人上升，政府採取措施提高人們對妊娠測試作為預防措施的認知，預計將為未來幾年的市場成長鋪平新的道路。根據世界計劃生育組織2022年發布的一項調查顯示，41個國家約有50%的女性使用避孕器來防止懷孕。其中22個位於撒哈拉以南非洲。

全球快速不孕症和妊娠檢測套組市場根據產品、測試類型、最終用戶和地區進行細分。根據產品，市場分為快速妊娠檢測套組和快速不孕症檢測套組。依檢測類型，分為尿液檢測套組盒和血液檢測檢測套組。根據最終用戶，市場可分為醫院、居家醫療機構和其他。按地區分析，涵蓋北美、歐洲、亞太、拉丁美洲以及中東和非洲。

主要發現

根據產品，快速妊娠測試領域預計將在 2024 年至 2033 年期間佔據市場主導地位。

根據測試類型，尿液檢查快速測試套件預計在預測期內呈現最高成長。

根據最終用戶，居家醫療領域預計在預測期內將大幅成長。

根據地區，快速生育和妊娠檢測套組市場預計未來幾年在北美將強勁成長。

此報告可自訂。 （需支付額外費用和時間安排。）

  • 新產品開發/主要企業的產品矩陣
  • 監管指南
  • 根據客戶興趣提供額外的公司簡介
  • 按國家或地區進行的額外分析 - 市場規模和預測
  • 平均售價分析/價格分佈分析
  • 擴展公司簡介列表
  • 歷史市場資料
  • Excel 格式的主要企業詳細資料（包括位置、聯絡資訊、供應商/供應商網路等）

目錄

第 1 章 簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 重大投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會

第4章 快速生育和妊娠檢測套組市場（按產品）

  • 市場概況
  • 快速妊娠檢測套組
  • 快速生育力檢測套組

第 5 章快速生育和妊娠檢測套組市場（按測試類型）

  • 市場概況
  • 尿液檢查套件
  • 血液檢測套組
  • 其他

第6章 快速生育和妊娠檢測套組市場（按最終用戶）

  • 市場概況
  • 醫院
  • 居家醫療
  • 其他

第7章快速生育和妊娠檢測套組市場（按地區）

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國快速生育和妊娠檢測套組市場
    • 加拿大快速生育和妊娠檢測套組市場
    • 墨西哥的快速生育和妊娠檢測套組市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 德國快速生育和妊娠檢測套組市場
    • 法國快速不孕及妊娠檢測套組市場
    • 英國快速生育和妊娠檢測套組市場
    • 義大利快速生育和妊娠檢測套組市場
    • 西班牙快速生育和妊娠檢測套組市場
    • 其他歐洲國家快速生育和妊娠檢測套組市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 日本快速不孕及妊娠檢測套組市場
    • 中國快速不孕不育及妊娠檢測套組市場
    • 印度快速生育與妊娠檢測套組市場
    • 澳洲快速生育和妊娠檢測套組市場
    • 韓國快速生育和妊娠檢測套組市場
    • 亞太地區其他快速生育和妊娠檢測套組市場
  • 拉丁美洲、中東和非洲
    • 主要市場趨勢和機遇
    • 巴西的快速生育和妊娠檢測套組市場
    • 沙烏地阿拉伯的快速生育和妊娠檢測套組市場
    • 南非快速生育和妊娠檢測套組市場
    • 拉丁美洲其他地區、中東和非洲快速生育和妊娠檢測套組市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 前 10 家公司的產品映射
  • 競爭儀錶板
  • 競爭熱圖
  • 2023年主要企業的定位

第9章 公司簡介

  • Atlas Medical GmbH
  • Church And Dwight Co., Inc.
  • Everlywell, Inc.
  • Geratherm Medical AG
  • QuidelOrtho Corporation
  • Mylab Discovery Solutions Pvt. Ltd.
  • Salignostics
  • Abbott
  • SPD Swiss Precision Diagnostics GmbH
  • AdvaCare Pharma
簡介目錄
Product Code: A324421

The fertility and pregnancy rapid test kits market was valued at $1.5 billion in 2023, and is projected to reach $3.1 billion by 2033, growing at a CAGR of 7.4% from 2024 to 2033.

Fertility and Pregnancy Rapid Test Kits Market - IMG1

Fertility and pregnancy rapid test kits are over-the-counter diagnostic tools designed to quickly detect hormones in urine or saliva that indicate a woman's fertility status or pregnancy. These tests provide a convenient and private way for individuals to monitor their reproductive health without the need for a healthcare professional's intervention. Pregnancy test kits detect the presence of human chorionic gonadotropin, a hormone produced during pregnancy, while fertility test kits detect luteinizing hormone or estrogen, which are critical for ovulation.

The global fertility and pregnancy rapid test kits market is witnessing robust growth due to factors such as rise in awareness about reproductive health and the convenience of at-home testing, especially among individuals trying to conceive. In addition, alarming rise in infertility rates due to lifestyle factors and delayed childbearing is driving a greater need for fertility test kits among couples seeking to conceive. According to a study published today by the World Health Organization in 2023, around 17.5% of the adult population experience infertility. The Infertility Statistics 2024 revealed that 48.5 million couples experience infertility globally. This highlights the urgent need for fertility test kits to help individuals monitor their fertility cycles and make informed decision. Moreover, the market growth is significantly driven by the relatively low cost of fertility and pregnancy rapid test kits makes them an affordable option for individuals seeking to monitor their reproductive health without the expense of frequent doctor visits. Furthermore, the widespread availability of these kits in both physical retail stores and online marketplaces makes them easy for consumers to access, thus contributing to the market growth. Early detection of pregnancy, especially for women with irregular cycles or those who want to confirm pregnancy quickly, is further augmenting the demand for pregnancy test kits. Despite advancements, some test kits may still provide false positives or false negatives, which significantly hampers the market growth. In addition, rise of other reproductive health technologies, such as digital ovulation trackers or mobile apps that offer more detailed insights, may reduce the demand for traditional test kits, thereby restraining the market growth. On the contrary, innovations in test kit technology, including greater accuracy, user-friendly designs, and faster results, have expanded the appeal and reliability of these products, which are expected to offer remunerative opportunities for the expansion of the global market during the forecast period. In addition, government initiatives to increase awareness about pregnancy testing as a preventative measure due to rise in burden of unplanned pregnancies and alarming rise in rate of abortion are anticipated to open new avenues for the growth of the market in the coming years. According to a 2022 study published by the World Family Planning, approximately 50% of the women across 41 countries use contraceptives to prevent pregnancy. Among these, 22 countries were from sub-Saharan Africa alone.

The global fertility and pregnancy rapid test kits market is segmented into product, test type, end user, and region. On the basis of the product, the market is bifurcated into pregnancy rapid tests and fertility rapid tests. By test type, it is classified into urine-based test kits and blood-based test kits. Depending on end user, it is divided into hospitals, homecare settings, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product, the pregnancy rapid tests segment is expected to dominate the market from 2024 to 2033.

On the basis of test type, the urine-based test kits rapid tests segment is anticipated to exhibit the highest growth during the forecast period.

Depending on end user, the homecare settings segment is projected to grow at a notable pace throughout the forecast period.

Region wise, the fertility and pregnancy rapid test kits market is likely to witness strong growth in In North America in the coming years.

Competition Analysis

Competitive analysis and profiles of the major players in the global fertility and pregnancy rapid test kits market include Atlas Medical GmbH, Church & Dwight Co., Inc., Everlywell, Inc., Geratherm Medical AG, QuidelOrtho Corporation, Mylab Discovery Solutions Pvt. Ltd., Salignostics , Abbott, SPD Swiss Precision Diagnostics GmbH, and AdvaCare Pharma. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • New Product Development/ Product Matrix of Key Players
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Average Selling Price Analysis / Price Point Analysis
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Pregnancy Rapid Tests
  • Fertility Rapid Tests

By Test Type

  • Urine-based Test Kits
  • Blood-based Test Kits
  • Others

By End User

  • Hospitals
  • Homecare Settings
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Atlas Medical GmbH
    • Church & Dwight Co., Inc.
    • Everlywell, Inc.
    • Geratherm Medical AG
    • QuidelOrtho Corporation
    • Mylab Discovery Solutions Pvt. Ltd.
    • Salignostics
    • Abbott
    • SPD Swiss Precision Diagnostics GmbH
    • AdvaCare Pharma

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Pregnancy Rapid Tests
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Fertility Rapid Tests
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY TEST TYPE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Test Type
  • 5.2. Urine-based Test Kits
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Blood-based Test Kits
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Others
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Homecare Settings
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Test Type
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Fertility and Pregnancy Rapid Test Kits Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Test Type
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Fertility and Pregnancy Rapid Test Kits Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Test Type
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Fertility and Pregnancy Rapid Test Kits Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Test Type
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Test Type
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Fertility and Pregnancy Rapid Test Kits Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Test Type
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Fertility and Pregnancy Rapid Test Kits Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Test Type
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Fertility and Pregnancy Rapid Test Kits Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Test Type
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Fertility and Pregnancy Rapid Test Kits Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Test Type
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Fertility and Pregnancy Rapid Test Kits Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Test Type
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest Of Europe Fertility and Pregnancy Rapid Test Kits Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Test Type
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Test Type
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Fertility and Pregnancy Rapid Test Kits Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Test Type
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Fertility and Pregnancy Rapid Test Kits Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Test Type
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Fertility and Pregnancy Rapid Test Kits Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Test Type
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. Australia Fertility and Pregnancy Rapid Test Kits Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Test Type
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Fertility and Pregnancy Rapid Test Kits Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Test Type
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Fertility and Pregnancy Rapid Test Kits Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Test Type
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Test Type
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Fertility and Pregnancy Rapid Test Kits Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Test Type
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Fertility and Pregnancy Rapid Test Kits Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Test Type
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Fertility and Pregnancy Rapid Test Kits Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Test Type
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Fertility and Pregnancy Rapid Test Kits Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Test Type
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping Of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Atlas Medical GmbH
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Church And Dwight Co., Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Everlywell, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Geratherm Medical AG
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. QuidelOrtho Corporation
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Mylab Discovery Solutions Pvt. Ltd.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Salignostics
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Abbott
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. SPD Swiss Precision Diagnostics GmbH
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. AdvaCare Pharma
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments